Deepak Nagra
-
- Long-Term Effects of COVID-19 3
-
- COVID-19 Clinical Research Studies 3
-
- Sarcoidosis and Beryllium Toxicity Research 4
-
- Immunodeficiency and Autoimmune Disorders 3
-
- Systemic Lupus Erythematosus Research 3
- Rheumatoid Arthritis Research and Therapies 3
-
- COVID-19 and healthcare impacts 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
Deepak Nagra
19 papers receiving 124 citations
Peers
Comparison fields: 5 of 54
- Neurology 40
- Infectious Diseases 47
- Dermatology 15
- Critical Care and Intensive Care Medicine 7
- Epidemiology 34
Countries citing papers authored by Deepak Nagra
This map shows the geographic impact of Deepak Nagra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Nagra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Nagra more than expected).
Fields of papers citing papers by Deepak Nagra
This network shows the impact of papers produced by Deepak Nagra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Nagra. The network helps show where Deepak Nagra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Deepak Nagra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 15 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 35 | |
| 17 | 2021 | 2 | |
| 18 | 2021 | 1 | |
| 19 | 2020 | 5 | |
| 20 | 2020 | 1 |
About Deepak Nagra
Deepak Nagra is a scholar working on Rheumatology, Internal Medicine, Oncology, Infectious Diseases and Neurology, having authored 25 papers that have together received 124 indexed citations. Recurring topics across this work include Sarcoidosis and Beryllium Toxicity Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), COVID-19 Clinical Research Studies (3 papers), Systemic Lupus Erythematosus Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Long-Term Effects of COVID-19 (3 papers), COVID-19 and healthcare impacts (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Neurology (40 citations), Infectious Diseases (47 citations), Dermatology (15 citations), Critical Care and Intensive Care Medicine (7 citations) and Epidemiology (34 citations). Deepak Nagra has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include James Galloway, Maryam Adas, April Buazon, Jennifer Hannah, Sam Norton, Mark Russell, Mark Yates, Katie Bechman, Patrick Gordon and Andrew I Rutherford. Their work appears in journals such as Lara D. Veeken, The Journal of Rheumatology, Annals of the Rheumatic Diseases, Vaccines and Clinical and Experimental Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.